| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |